Recent Finacing
Recent Raise
Ambit Biosciences is a San Diego-based biotech that discovers and develops small-molecule kinase inhibitors, including oral FLT3 inhibitor quizartinib for AML and JAK2, BRAF, pan-HER candidates, collaborating with Astellas.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors